Chan Sheng-Chieh, Chang Joseph T, Lin Chien-Yu, Ng Shu-Hang, Wang Hung-Ming, Liao Chun-Ta, Chang Chee-Jen, Lin Shao-Yu, Yen Tzu-Chen
Department of Nuclear Medicine and Molecular Imaging Center, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Nucl Med Commun. 2011 Nov;32(11):989-96. doi: 10.1097/MNM.0b013e3283495662.
To investigate the prognostic impact of different 2-[fluorine-18]fluoro-2-deoxy-D-glucose positron emission tomography (¹⁸F-FDG PET) parameters in patients with advanced nasopharyngeal carcinoma (NPC).
A total of 196 patients with primary stage III-IVb NPC were included in the study. The following parameters derived from pretreatment ¹⁸F-FDG PET were determined: metabolic tumor volume and total lesion glycolysis (TLG) of the primary tumor, maximal standardized uptake value of the primary tumor and the neck lymph nodes. Multivariable Cox proportional hazards models were used to identify independent predictors of survival.
Multivariable analysis demonstrated that TLG values greater than 330 independently predicted overall survival (P=0.0014) and disease-free survival (P=0.0005). We identified IVa-b stage and TLG values greater than 330 as independent predictors of local failure-free survival. In addition, a high maximal standardized uptake value of the neck lymph nodes (P=0.005), male sex (P=0.041), and stage IVa-b (P=0.009) independently predicted distant failure-free survival. A TLG cutoff value of 330 allowed a better stratification of overall survival and disease-free survival rates. A scoring system combining significant PET parameters and traditional prognostic factors was formulated to define distinct prognostic groups for local failure-free survival and distant failure-free survival. There was a stepwise decrease in the 5-year local (97.7, 90.4, and 47.3%, P<0.0001) and distant control rates (96.8, 88.5, 73.9, and 36.4%, P<0.0001) according to the distinct prognostic scores.
In patients with advanced NPC, the prognostic significance of ¹⁸F-FDG PET parameters seems to depend on the specific endpoint. The combination of PET metabolic parameters with traditional risk factors may significantly improve prognostic stratification for this group of patients.
探讨不同的2-[氟-18]氟-2-脱氧-D-葡萄糖正电子发射断层扫描(¹⁸F-FDG PET)参数对晚期鼻咽癌(NPC)患者预后的影响。
本研究共纳入196例Ⅲ-Ⅳb期原发性NPC患者。测定了以下源自治疗前¹⁸F-FDG PET的参数:原发肿瘤的代谢肿瘤体积和总病变糖酵解(TLG)、原发肿瘤及颈部淋巴结的最大标准化摄取值。采用多变量Cox比例风险模型来确定生存的独立预测因素。
多变量分析表明,TLG值大于330可独立预测总生存期(P = 0.0014)和无病生存期(P = 0.0005)。我们确定Ⅳa-b期和TLG值大于330是无局部复发生存期的独立预测因素。此外,颈部淋巴结的高最大标准化摄取值(P = 0.005)、男性(P = 0.041)和Ⅳa-b期(P = 0.009)可独立预测无远处转移生存期。TLG临界值为330时能更好地对总生存期和无病生存率进行分层。制定了一个结合重要PET参数和传统预后因素的评分系统,以定义无局部复发生存期和无远处转移生存期的不同预后组。根据不同的预后评分,5年局部控制率(97.7%、90.4%和47.3%,P<0.0001)和远处控制率(96.8%、88.5%、73.9%和36.4%,P<0.0001)呈逐步下降。
在晚期NPC患者中,¹⁸F-FDG PET参数的预后意义似乎取决于具体的终点。PET代谢参数与传统危险因素的结合可能显著改善该组患者的预后分层。